Phase
Condition
Post-traumatic Stress Disorders
Opioid Use Disorder
Treatment
Prolonged exposure therapy
Financial incentives
Treatment as usual
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
>18 years old
Maintained on a stable methadone or buprenorphine dose for >1 month prior to thestudy
Meet current DSM-5 posttraumatic stress disorder criteria based on the ClinicianAdministered PTSD Scale for DSM-5
Participants receiving psychotropic medications must be maintained on a stable dosefor >1 month prior to enrollment.
Exclusion
Exclusion Criteria:
Current delusions or hallucinations, unstable bipolar disorder, imminent risk forsuicide as assessed by the Mini International Neuropsychiatric Interview
Cognitive impairment as evidenced by scores <22 on the Videoconference-based MiniMental Status Examination (MMSE; Folstein, et al., 1975)
Enrolled in another ongoing evidence-based treatment for PTSD.
Pregnancy as verified by pregnancy test
No access to cellular service
Study Design
Study Description
Connect with a study center
University of Vemont
Burlington, Vermont 05401
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.